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Vibrio parahaemolyticus is a leading cause of seafood-borne infections in the US. This
organism has a high genetic diversity that complicates identification of strain relatedness
and epidemiological investigations. However, sequence-based analysis methods are
promising tools for these identifications. In this study, Multi-Locus Sequence Typing
(MLST) and Multiple-Locus Variable-Number Tandem-Repeat Analysis (MLVA) was
performed on 58 V. parahaemolyticus isolates (28 of oyster and 30 of clinical origin), to
identify differences in phylogeny. The results obtained by both methods were compared
to Pulsed-Field Gel Electrophoresis (PFGE) patterns determined in a previous study.
Forty-one unique sequence types (STs) were identified by MLST among the 58 isolates.
Almost half of the isolates (22) belonged to a new ST and added to the MLST database. A
ST could not be generated for 5 (8.6%) isolates, primarily due to an untypable recA locus.
Analysis with eBURST did not identify any clonal complex among the strains analyzed
and revealed 37 singeltons with 4 of them forming 2 groups (1 of them SLV, and the
other a DLV). An established MLVA assay, targeting 12 total genes through three separate
4-plex PCRs, was successfully adapted to high resolution melt (HRM) analysis with faster
and easier experimental setup; resulting in 58 unique melt curve patterns. HRM-MLVA
was capable of differentiating isolates within the same PFGE cluster and having the
same ST. Conclusively, combining the three methods PFGE, MLST, and HRM-MLVA, for
the phylogenetic analysis of V. parahaemolyticus resulted in a high resolution subtyping
scheme for V. parahaemolyticus. This scheme will be useful as a phylogenetic research
tool and as an improved method for outbreak investigations for V. parahaemolyticus.
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Introduction
Vibrio parahaemolyticus can cause acute gastroenteritis
associated with consumption of raw or undercooked seafood
(Nishibuchi and DePaola, 2005). Presently, this bacterium
represents the most common cause for seafood-associated
infections in the United States (Iwamoto et al., 2010). V.
parahaemolyticus has shown a high rate of recombination and
mutation which leads to a high genetic diversity (Gonzalez-
Escalona et al., 2008). V. parahaemolyticus isolates are frequently
characterized for their virulence gene profile, serotype, ribotype,
and/or Pulsed-Field Gel Electrophoresis (PFGE) pattern for
research studies and epidemiological investigations (Broberg
et al., 2011; Jones et al., 2012; Paranjpye et al., 2012; Banerjee
et al., 2014; Xu et al., 2015). However, there are several
phylogenetic and evolutionary methodologies for differentiation
of V. parahaemolyticus, such as Multi-Locus Sequence Typing
(MLST) and Multiple-Locus Variable-Number Tandem-Repeat
Analysis (MLVA), which may provide greater discrimination.
For this study, we selected two sequence-based typing
methods, MLST andMLVA.MLST is based on sequence diversity
of loci which are generally well-conserved, or under purifying
selection, as is the case with housekeeping genes. MLST is a
frequently used typing method for many organisms and the
development of a public database (PubMLST) has simplified
sequence analysis and identification of evolutionary relationships
within bacterial species (Maiden et al., 1998; Perez-Losada et al.,
2013).MLSTwas selected to examine the current strain collection
based on the previous success of the technique for characterizing
diverse environmental and clinical V. parahaemolyticus isolates
(Gonzalez-Escalona et al., 2008) and to add a diverse set of
isolates to the MLST database. MLVA has also been used to
distinguish isolates with little genetic variation. MLVA uses PCR
for amplification of size polymorphisms in several Variable-
Number Tandem-Repeat (VNTR) loci (Lindstedt, 2005). The
VNTRs are highly polymorphic and are well suited for
differentiation of bacterial isolates (Lindstedt, 2005; van Belkum,
2007). MLVA was selected for use in this study as it is able
to differentiate between indistinguishable PFGE patterns for V.
parahaemolyticus (Hayat et al., 1993; Harth-Chu et al., 2009) or
identical MLST sequence types (STs) in other organisms (Maiden
et al., 1998, 2013). Recently, MLVA was used for epidemiological
analysis for discrimination of clinical and environmental V.
parahaemolyticus isolates with indistinguishable Direct Genome
Restriction Enzyme Analysis (DGREA) patterns (Harth-Chu
et al., 2009; Garcia et al., 2012). Generally, the PCR products from
MLVA are separated by agarose gel or capillary electrophoresis
(CE) (Lindstedt et al., 2013). However, differentiation of
amplification products using high resolution melt (HRM)
analysis has been described for MLVA assays in other organisms
(Fortini et al., 2007).
The objective of this study was to evaluate the combined use
of MLST and the HRM-MLVA sequence-based methods
for discrimination of environmental and clinical V.
parahaemolyticus isolates previously characterized by other
fingerprinting methods, such as PFGE (Ludeke et al., 2014).
MLST was selected to identify phylogenetic relationships while
MLVA was applied with the hypothesis that it will further
discriminate isolates with identical STs. In order to achieve
this objective, an HRM-MLVA protocol for rapid and simple
characterization of V. parahaemolyticus isolates was developed.
This is the first study, to the authors’ knowledge, to use the
combined approach of the subtyping methods MLST, HRM-




For the MLST and MLVA analysis, 58 V. parahaemolyticus
isolates were selected; among those were 28 environmental
(oyster) and 30 clinical isolates. Isolates were selected to represent
multiple collection states and serotypes (Table 1). Each isolate
was inoculated into Luria Bertani broth with 1% NaCl and
incubated with shaking overnight at 35◦C. Afterwards, 1mL of
the overnight culture was transferred to a 1.5mLmicrocentrifuge
tube, heated to 100◦C for 10min, and placed in ice for 5min. The
samples were stored at−20◦C until used as a PCR template.
Multi-Locus Sequence Typing (MLST)
MLST was performed as described in the protocol for Vibrio
parahaemolyticus (Gonzalez-Escalona et al., 2008). The PCR
products were purified using a PCR purification kit (Qiagen,
Valencia, CA) with a total elution volume of 25µL. The purified
samples were sequenced on an ABI 3730 × l sequencer at
McLab (South San Francisco, CA). Sequences were analyzed
with BioEdit software 7.1.9 (Abbott, Carlsbad, CA). The allelic
and sequence type (ST) identification was determined using
the MLST database (http://pubmlst.org/vparahaemolyticus). In
the cases where whole genome sequence data was available,
sequences were de novo assembled using CLC Genomics
Workbench software 7.0.3 (CLCbio, Germantown, MD) and
consensus assemblies submitted to the MLST database for allelic
and ST identification.
For identification of clonal complexes, eBURST version 3
was used (http://eburst.mlst.net/). As reported previously, two
different STs were considered single-locus variant (SLV) when
they differed by a single locus; a double-locus variant (DLV) has
two different loci (Gonzalez-Escalona et al., 2008). To be part of
a clonal complex, isolates needed to share at least six out of seven
alleles.
The minimum evolution tree of the concatenated sequences
of the seven loci was built based on the method of Kimura-2-
parameter in Mega 6 (Tamura et al., 2013). The ratio between
the number of synonymous and non-synonymous substitutions,
showing the type of selection at each locus, was calculated using
the method of Nei and Gojobori in Mega 6. The hypotheses of
neutrality (dS= dN), purifying selection (dS/dN > 1), and positive
selection (dS/dN < 1) were tested.
Multiple-Locus Variable-Number Tandem-Repeat
Analysis (MLVA)
Three multiplex real-time-PCR assays using HRM curve analysis
were performed with the LightCycler R© 480 High Resolution
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TABLE 1 | Isolates used in this study and their sequence types (ST).
Isolate ID Source of isolate Collection state Serotype tdh trh Allele types ST
dnaE gyrB recA dtdS pntA pyrC tnaA
FDA_R2 Oyster TX O3:Kuta − + 86 300 17 55 12 54 86 729c
FDA_R5 Oyster TX O10:Kut − + 214 329 30 19 165 69 26 730
FDA_R10 Oyster FL O1:Kut + + 142 29 10 7 4 24 20 313
FDA_R12 Oyster LA O4:K8 + + 20 25 15 6 7 11 4 32
FDA_R13 Oyster LA O4:K10 − − 241 330 205 253 28 22 188 732
FDA_R16 Oyster FL O4:K9 + + 20 25 15 13 7 11 5 34
FDA_R17 Oyster FL O4:Kut − − 14 30 49 11 49 11 13 536
FDA_R21 Oyster TX O5:Kut − + 9 21 15 13 4 10 26 12
FDA_R26 Oyster NJ O4:K8 + + 20 25 15 6 7 11 4 32
FDA_R29 Oyster FL O11:Kut − − 235 22 25 273 164 254 20 734
FDA_R30 Oyster FL O1:Kut + + 17 16 UT 36 15 31 26 −
FDA_R45 Oyster WA O5:Kut − + 37 14 14 9 14 34 26 61
FDA_R47 Oyster AL O4:K8 + + 20 25 15 6 7 11 4 32
FDA_R51 Oyster AL O8:Kut + + 60 106 31 72 66 62 65 676
FDA_R52 Oyster WA O3:Kut − + 4 13 11 38 18 46 23 735
FDA_R60 Oyster ME O10:Kut − + 63 326 231 13 48 120 24 736
FDA_R62 Oyster ME O1:Kut − + 31 327 UT 157 14 3 20 −
FDA_R74 Oyster VA O4:K34 − − 26 58 53 19 28 9 26 108
FDA_R75 Oyster VA O8:Kut + + 60 106 31 72 66 62 65 676
FDA_R86 Oyster FL O6:Kut − − 45 336 143 7 171 255 36 737
FDA_R87 Oyster FL O8:K70 + + 145 177 140 158 4 132 104 320
FDA_R94 Oyster PEIb (Canada) O3:K5 − + 47 328 UT 13 2 256 23 −
FDA_R125 Oyster FL O11:Kut + − 17 331 235 23 33 137 94 739
FDA_R126 Oyster FL O4:K42 − − 36 285 25 250 26 227 26 740
FDA_R135 Oyster SC O3:Kut − − 26 16 41 224 31 32 23 741
FDA_R136 Oyster SC O1:K20 + + 31 16 32 36 33 11 19 775
FDA_R143 Oyster FL O5:Kut − − 17 64 137 60 94 11 51 743
FDA_R149 Oyster FL O1:Kut + + 142 29 10 7 4 24 20 313
CDC_K4556_1 Clinical LA O1:K25 − − 31 82 236 35 23 26 51 744
CDC_K4557 Clinical LA O1:K33 − − 28 4 82 88 63 187 1 799
CDC_K4588 Clinical ME O5:Kut − + 56 16 237 8 33 59 20 746
CDC_K4857_1 Clinical HI O5:K17 − − 35 43 38 21 31 35 37 79
CDC_K4858 Clinical HI O4:K4 − − 27 84 127 139 54 124 37 283
CDC_K4981 Clinical OK O1:Kut − − 17 327 13 8 172 32 181 748
CDC_K5009_1 Clinical MA O4:K53 + + 5 71 238 162 26 11 107 749
CDC_K5010_1 Clinical MA O1:Kut + − 3 4 19 4 29 4 22 3
CDC_K5058 Clinical TX O3:K6 + − 3 4 19 4 29 4 22 3
CDC_K5067 Clinical SD O1:K56 + + 31 16 13 36 33 11 19 775
CDC_K5073 Clinical MD O3:K56 + + 17 57 52 285 44 28 36 750
CDC_K5125 Clinical MS O3:Kut − − 195 263 187 75 23 198 190 772
CDC_K5276 Clinical NY O11:Kut + + 222 128 21 69 46 236 12 631
CDC_K5278 Clinical WA O4:K12 + + 21 15 1 23 23 21 16 36
CDC_K5282 Clinical HI O5:Kut − − 19 217 89 175 UT 62 51 −
CDC_K5306 Clinical GA O4:K9 + + 20 25 15 13 7 11 5 34
CDC_K5323_1 Clinical VA O5:K17 − + 83 82 73 83 4 77 58 674
CDC_K5324_1 Clinical VA O1:K20 + + 56 16 32 286 14 11 19 752
CDC_K5331 Clinical GA O4:K8 + − 11 48 UT 48 26 48 26 −
CDC_K5345_1 Clinical IA O4:K12 + + 21 15 1 23 23 21 16 36
(Continued)
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TABLE 1 | Continued
Isolate ID Source of isolate Collection state Serotype tdh trh Allele types ST
dnaE gyrB recA dtdS pntA pyrC tnaA
CDC_K5428 Clinical NV O1:Kut + + 22 28 17 13 8 19 14 199
CDC_K5433 Clinical WA O4:Kut + + 21 15 1 23 23 21 16 36
CDC_K5436 Clinical WA O4:Kut + + 21 15 1 23 23 21 16 36
CDC_K5439 Clinical WA O4:K8 + − 11 48 3 48 26 48 26 189
CDC_K5485 Clinical NC O6:K18 − − 29 5 22 12 20 22 25 50
CDC_K5528 Clinical GA O4:K68 + − 3 4 19 4 29 4 22 3
CDC_K5582 Clinical GA O11:Kut + + 222 128 21 69 46 236 12 631
CDC_K5618 Clinical NY O10:Kut + + 223 106 31 221 45 171 165 636
CDC_K5621 Clinical NY O1:Kut − + 39 9 27 39 3 37 30 65
CDC_K5635 Clinical MD O5:K30 − − 158 131 31 287 128 43 189 753
aut = untypable.
bPEI = Prince Edward Island.
cnovel allele type and novel ST in bold.
Melting Master Kit (Roche, Indianapolis, IN). The primer
sequences utilized in this study are listed inTable 2 and have been
previously described (Harth-Chu et al., 2009). These primers
were utilized as unmodified oligonucleotides since HRM was
used as the detection method rather than CE. Each reaction
mixture for the multiplex PCR A and B (Multi A and B)
had a final volume of 20µL and consisted of: 1X master mix
solution (Roche), 2mM MgCl2 (Roche), 0.2µM each primer
(Integrated DNA Technologies; IDT, Coralville, IA), and 5µL
boiled template. For multiplex PCR C (Multi C), reaction
concentrations were the same as for Multi A and B, except
for primer pair VP2-07; 0.4µM of each primer was used. The
temperature program was as described previously for Multi A
and B (Harth-Chu et al., 2009): Initial denaturation at 95◦C for
15min, followed by 20 cycles of a touchdown PCR consisting
of denaturation at 94◦C for 30 s, annealing starting at 63◦C and
decreasing 0.2◦C per cycle for 1.5min, and elongation at 72◦C
for 1min. A final 10 cycles of denaturation at 94◦C for 30 s,
annealing at 59◦C for 1.5min, and elongation at 72◦C for 1min
was used. The cycling program of Multi C included the same
initial denaturation as for Multi A and B; cycling consisted of
30 cycles of denaturation at 94◦C for 30 s, annealing at 61◦C for
1.5min, and elongation at 72◦C for 1min. A final annealing step
at 60◦C for 30min completed both cycling programs. The melt
curve analysis was performed using the Roche High Resolution
Melting Kit protocol. The temperature program for the HRM
analysis started at 95◦C for 1min with a ramp of 4.4◦C per s,
followed by 40◦C for 1min with a ramp of 2.2◦C per s, 60◦C for
1 s with a ramp of 4.4◦C per s and a continuous step at 95◦C.
For the PCR amplification andHRM analysis a LightCycler R© 480
(Roche) was used.
Due to overlapping peaks in Multi A and C, the presence
of the target loci VNTR5 and VNTR7, VNTR3, and VP2-07
were confirmed using simplex real-time-PCR for each gene
with the same PCR reaction conditions and cycling parameters
as described for the multiplex, but with omission of the
three other primer sets. The melt curves were analyzed with
BioNumerics software 6.6 with a customized script (Applied
Maths, Austin, TX). This script compares the melting curves of
each multiplex PCR, as well as a combination of all curves from
the three multiplex PCRs. The combined dendrogram of all three
multiplex PCR was built based on the Pearson correlation of
average trend curves in BioNumerics as well. This dendrogram
was also converted to a rendered rooted tree.
Results
Multi-Locus Sequence Typing (MLST)
From the 58 V. parahaemolyticus isolates analyzed, MLST
resulted in 41 different STs (Table 1). Four (6.9%) and one (1.7%)
of the isolates were untypeable for recA and pntA, respectively.
For those strains, no ST could be assigned. Twelve (42.9%) of the
oyster and ten (40.0%) of the clinical isolates were a novel ST.
The most frequently identified STs were ST36 (13.3%) and ST3
(10.0%) in clinical isolates and ST32 (10.7%), ST313 (7.1%), and
ST676 (7.1%) in oyster isolates.
All loci showed ratios of synonymous and non-synonymous
substitutions (dN /dS) below 1 and therefore under purifying
selection, as expected for housekeeping genes. eBURST analysis
divided the 53 isolates for which a ST could be identified into
37 singletons and two groups: one SLV and one DLV (data not
shown). No clonal complexes could be identified; demonstrating
that none of the STs identified in this study share more than
six alleles and, therefore, belong to different V. parahaemolyticus
lineages.
A minimum evolution tree was constructed using the
concatenated sequences of each allele (Figure 1). The isolates
grouped into two main clusters, or lineages (I and II), with
each lineage containing ST of clinical and oyster isolates.
Isolates with the same ST generally had the same serotype;
ST631 isolates possessed serotype O11:Kut, ST676 were serotype
O8:Kut, ST36 were serotype O4:K12 or O4:Kut, and ST313 were
serotype O1:Kut. However, the three ST3 isolates had all different
serotypes.
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TABLE 2 | Primer sequences including their amplification product length and melting temperature for MLVA multiplex PCR.
Multiplex-PCR Locus Primer 5′-3′ Sequence Product length [bp] Melting temperature Tm [◦C] References
Multi A VP1-11 VP1-11 F CTGCCTGGAGAATTGGCTTA 854 95 8
VP1-11 R TGAGCCTGAAGCTGAAAACA
VP2-03 VP2-03 F CATAAACGAGCGACACGAGA 168 57 8
VP2-03 R GCGCAAAAATTCATTGTGATT
VPTR5 VPTR5 F GCTGGATTGCTGCGAGTAAGA 204 82 22
VPTR5 R AACTCAAGGGCTGCTTCGG
VPTR7 VPTR7-1F TATCTACAAAGGTGGCGGAGAT 200 80 8
VPTR7-1R AAGGTGTTACTTGTTCCAGACG
Multi B VP1-17 VP1-17 F TCAACACGAGCTTGATCACC 206 69 8
VP1-17 R GAAATCCGGAGTACCTGCAA
VP1-10 VP1-10 F CGTCTTGCTCGTGAACGTAA 955 94 8
VP1-10 R TCATTAAGTCAGGCGTGCTG
VPTR1 VPTR1 F TAACAACGCAAGCTTGCAACG 253 54 22
VPTR1 R TCATTCTCGCCACATAACTCAGC
VPTR8 VPTR8 F ACATCGGCAATGAGCAGTTG 301 89 22
VPTR8 R AAGAGGTTGCTGAGCAAGCG
Multi C VP2-07 VP2-07 F TGATTTTGAAGCAGCGAAGA 296 98, smaller peak at 74 8
VP2-07 R TTTGTGACTGCTGTCCTTGC
VPTR3 VPTR3 F CGCCAGTAATTCGACTCATGC 331 77 22
VPTR3 R AAGACTGTTCCCGTCGCTGA
VPTR4 VPTR4 F AAACGTCTCGACATCTGGATCA 227 85 22
VPTR4 R TGTTTGGCTATGTAACCGCTCA




The 58 V. parahaemolyticus isolates from this study were further
analyzed by MLVA with HRM analysis. Three multiplex PCRs
covering twelve different loci were used. Each multiplex PCR
generated reproducible melting curve profiles of select isolates
(data not shown). Table 3 shows the percentage of isolates from
which each target sequence in the MLVA scheme was amplified.
From the Multi A, VP2-03, VPTR7, or VP1-11 was not amplified
in 10% and 14.3%, 46.6% and 39.3%, or 3.3% and 3.6% of
clinical and oyster isolates, respectively; VPTR5 was amplified
from all isolates. InMulti B, VP1-10 or VPTR8 was not present in
96.7% and 17.9%, 23.3% and 17.9% of clinical and oyster isolates,
respectively; VPTR1 andVP1-17 was amplified in all isolates with
the exception of 6.7% of clinical isolates not amplifying VPTR1.
From Multi C, VPRT6 was not amplified in 83.3% and 85.7%
of clinical and oyster isolates, respectively. All isolates amplified
VPTR4, VPTR3, andVP2-07, with the exception of 3.6% of oyster
isolates for VPTR4.
Using the trend curves of each individual multiplex PCR,
dendrograms were constructed (data not shown). Each multiplex
PCR generally clustered the isolates based on their serotypes and
ST. The individual multiplex PCR dendrograms demonstrated
the ability of MLVA to differentiate between the same ST (data
not shown).
Comparison of MLST, MLVA, and PFGE
Based on the hypothesis MLVA can differentiate isolates with
the same ST and PFGE pattern, these isolates’ MLVA patterns
were compared to the MLST data, as well as previously
published PFGE results (Ludeke et al., 2014). To compare these
methods, dendrograms were built of the combined melting
curves from the three MLVA multiplex PCRs and correlated
to the PFGE cluster and ST of each isolate. MLVA allowed
further differentiation of isolates with identical STs and PFGE
clusters (Figure 2). Specifically, the isolates with ST3 and ST36
share the same PFGE cluster, but were distinguishable by MLVA
melting curve profiles (Figure 3). The dendrogram with only
ST3 and ST36 isolates showed ST-specific clusters, but separation
within those clusters based on the combined melting curves
of MLVA.
Discussion
This study analyzed 58 V. parahaemolyticus isolates by MLST
and a newly-developed HRM-MLVA assay to investigate the
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FIGURE 1 | MLST minimum evolution tree of the 58 V. parahaemolyticus isolates. The tree was built with Mega six software using concatenated sequences.
The scale represents the evolutionary distance and the branches show bootstrap values above 50%.
relatedness of the isolates. The seven gene MLST protocol
reported in a previous study was employed in this study
(Gonzalez-Escalona et al., 2008). A different MLSTmethod using
ten housekeeping genes was described (Yan et al., 2011). Both
methods report the same level of discrimination; however, the
seven gene protocol was selected due to the availability of a public
repository for the data (http://pubmlst.org/vparahaemolyticus),
which allows comparisons to be made with isolates analyzed by
other researchers. With 22 novel STs, this study substantially
contributed to the diversity in the MLST database. Four of our
isolates were untypeable for recA. In a recently published study,
a V. parahaemolyticus strain contained a recA gene that was
fragmented by a 30 kb DNA insertion (Gonzalez-Escalona et al.,
2015). It is possible a similar insertion exists in the recA gene of
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TABLE 3 | Presence of individual MLVA genes in clinical and oyster isolates.
Multi A Multi B Multi C
VP2-03 VPTR7 VP1-11 VPTR5 VP1-10 VPTR1 VPTR8 VP1-17 VPTR4 VPTR3 VPTR6 VP2-07
Clinical isolates (n = 30) 27 16 29 30 1 28 23 30 30 30 5 30
Percentage (%) 90.0 53.3 96.7 100.0 3.3 93.3 76.7 100.0 100.0 100.0 16.7 100.0
Oyster isolates (n = 28) 24 17 27 28 23 28 23 28 27 28 4 28
Percentage (%) 85.7 60.7 96.4 100.0 82.1 100.0 82.1 100.0 96.4 100.0 14.3 100.0
some of the strains in the current study, but further analysis is
needed to confirm.
ST3, ST32, and ST36 were the STs that occurred most often
in our isolates, as well as in the public database. In our study,
the fourth most frequent ST observed was ST676, which is
one of the novel STs reported here. Two of these STs (ST3
and ST36) have been reported as part of clonal complexes
CC3 and CC36, respectively (Gonzalez-Escalona et al., 2008),
and correlated with outbreaks in multiple countries, including
the US and Chile (Fuenzalida et al., 2006; Martinez-Urtaza
et al., 2013). ST3 was identified as the ancestral ST of CC3
with ST27, ST42, and ST51 as SLVs. None of other STs from
CC3 were identified in this study. A previous study using
MLST on a set of clinical and environmental isolates from the
Pacific Northwest Region of the United States showed that some
environmental isolates were of ST3, suggesting a higher potential
for virulence than other environmental isolates (Turner et al.,
2013). In this study, three clinical isolates were ST3 and no
direct relationship to environmental or other clinical clades were
observed.
We developed an HRM-MLVA method, based on an existing
MLVAmethod that uses CE, for subtyping ofV. parahaemolyticus
and to differentiate between similar PFGE patterns or STs. The
CE method provides the actual number of tandem repeats while
HRM does not. However, the HRM analysis still recognizes
allelic variants and is able to distinguish between otherwise
indistinguishable strains. For example, the ST3, ST32, and ST36
strains in this study also shared common PFGE profiles, but
each isolate produced a unique HRM curve combination. This
resolving power of HRM-MLVA is similar to previous reports
of CE-MLVA, where Chilean isolates which shared a DGREA
pattern and were ST3 could be differentiated by CE-MLVA
(Gonzalez-Escalona et al., 2008; Harth-Chu et al., 2009). These
data demonstrate that the HRM-MLVA method developed in
this study provides similar discrimination as previously reported
for the CE-MLVA method and is suitable examination of V.
parahaemolyticus isolates. Additionally, the use of HRM-MLVA
on the LightCycler R©480 saves the step of electrophoretic
detection, thus minimizing the potential for cross contamination
by PCR amplicons during that additional handling
step.
The loci amplified in this study by MLVA are coding proteins
such as a putative hemolysin (VPTR4) and putative collagenase
(VPTR3) (Kimura et al., 2008). Most of these genes, could be
amplified from the current strain selection with the exception
of VPTR7 (Multi A), VP1-10 (Multi B), and VPTR6 (Multi C).
Nearly all clinical isolates failed to amplify the VP1-10 locus
and approximately half failed to amplify the locus VPTR7.
A failure to amplify VPTR7 from some shellfish isolates has
been reported previously (Harth-Chu et al., 2009). Fewer than
20% of isolates amplified VPTR6 in this study. Additionally, a
previous study found VPTR6 to be one of the few loci with high
genetic diversity (Harth-Chu et al., 2009). Together, these data
suggest that these two loci might not be suitable targets for future
MLVA studies, especially for environmental isolate screening.
Nonetheless, the HRM-MLVAmethod successfully discriminated
between otherwise indistinguishable V. parahaemolyticus
isolates.
Previous studies have employed multiple methods for
characterization and subtyping of V. parahaemolyticus isolates
from various sources. For example, DePaola et al. used a
combination of serotyping and ribotyping to identify types more
highly associated with clinical isolates (DePaola et al., 2003).
Turner et al. utilized REP-PCR, as fingerprint-based subtyping
method, followed byMLST to identify region-specific clades ofV.
parahaemolyticus (Turner et al., 2013). Banerjee et al. employed
PFGE, MLST, serotyping, and ribotyping to examine clinical V.
parahaemolyticus isolates and provided combinatorial analysis to
determine relatedness (Banerjee et al., 2014). However, none of
these previous studies utilized the combination of two highly
discriminatory, sequence-based methods as does the current
study.
This combined method approach described here using
PFGE, MLST, and MLVA has not been previously reported for
discrimination of V. parahaemolyticus isolates, but is similar to
approaches used for other organisms: for example, the Centers
for Disease Control and Prevention has used a combination
of PFGE followed by MLVA for epidemiological investigations
of STEC O157 to discriminate between closely related isolates
(Hyytia-Trees et al., 2006). Also, a combination of MLST
and MLVA has been used as an epidemiological tool for
distinguishing between clones of Listeria monocytogenes (Chenal-
Francisque et al., 2013).
This study used a combined method approach to increase
the discrimination of V. parahaemolyticus isolates. MLST
was able to determine the identity and the phylogenetic
relatedness of the isolates in this collection. As hypothesized, the
developed HRM-MLVA method further refined the relationship
of isolates by being able to distinguish between isolates with
indistinguishable PFGE groupings or STs. Our data demonstrates
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FIGURE 2 | Combined dendrogram of MLVA melting curves of the three multiplex PCRs built with BioNumerics software version 6.6. using Pearson
correlation and the unweighted pair group method using arithmetic averages (UPGMA). Isolates originated from oysters starting with “FDA,” isolates from
clinical origin labeled with “CDC.” The PFGE pattern designations are as previously reported (Ludeke et al., 2014).
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FIGURE 3 | Dendrogram of MLVA melting curves of the three multiplex PCRs for the isolates carrying ST3 and ST36 built with BioNumerics software
version 6.6. using Pearson correlation and the unweighted pair group method using arithmetic averages (UPGMA). The PFGE cluster designations are as
previously reported (Ludeke et al., 2014).
that a combination of PFGE, MLST, and HRM-MLVA would
be the most suitable approach for outbreak and evolutionary
investigations of V. parahaemolyticus, due to the high resolution
provided. In instances where further discrimination is needed,
and if available, next generation sequence data could be used to
determine relatedness or to generate subtyping results in silico.
Acknowledgments
This project was supported by an appointment of CL to the
Research Fellowship Program for the Center for Food Safety and
Applied Nutrition administered by the Oak Ridge Associated
Universities through a contract with the FDA.
References
Banerjee, S. K., Kearney, A. K., Nadon, C. A., Peterson, C. L., Tyler, K.,
Bakouche, L., et al. (2014). Phenotypic and genotypic characterization
of Canadian clinical isolates of Vibrio parahaemolyticus collected from
2000 to 2009. J. Clin. Microbiol. 52, 1081–1088. doi: 10.1128/JCM.
03047-13
Broberg, C. A., Calder, T. J., and Orth, K. (2011). Vibrio parahaemolyticus cell
biology and pathogenicity determinants. Microbes Infect. 13, 992–1001. doi:
10.1016/j.micinf.2011.06.013
Chenal-Francisque, V., Diancourt, L., Cantinelli, T., Passet, V., Tran-Hykes,
C., Bracq-Dieye, H., et al. (2013). Optimized Multilocus variable-number
tandem-repeat analysis assay and its complementarity with pulsed-field gel
electrophoresis and multilocus sequence typing for Listeria monocytogenes
clone identification and surveillance. J. Clin. Microbiol. 51, 1868–1880. doi:
10.1128/JCM.00606-13
DePaola, A., Ulaszek, J., Kaysner, C. A., Tenge, B. J., Nordstrom, J. L., Wells,
J., et al. (2003). Molecular, serological, and virulence characteristics of Vibrio
parahaemolyticus isolated from environmental, food, and clinical sources
in North America and Asia. Appl. Environ. Microbiol. 69, 3999–4005. doi:
10.1128/AEM.69.7.3999-4005.2003
Fortini, D., Ciammaruconi, A., De, S. R., Fasanella, A., Battisti, A., D’Amelio,
R., et al. (2007). Optimization of high-resolution melting analysis for low-
cost and rapid screening of allelic variants of Bacillus anthracis by multiple-
locus variable-number tandem repeat analysis. Clin. Chem. 53, 1377–1380. doi:
10.1373/clinchem.2007.085993
Fuenzalida, L., Hernandez, C., Toro, J., Rioseco, M. L., Romero, J., and Espejo, R.
T. (2006). Vibrio parahaemolyticus in shellfish and clinical samples during two
large epidemics of diarrhoea in southern Chile. Environ. Microbiol. 8, 675–683.
doi: 10.1111/j.1462-2920.2005.00946.x
Garcia, K., Gavilan, R. G., Hofle, M. G., Martinez-Urtaza, J., and Espejo, R. T.
(2012). Microevolution of pandemic Vibrio parahaemolyticus assessed by the
number of repeat units in short sequence tandem repeat regions. PLoS ONE
7:e30823. doi: 10.1371/journal.pone.0030823
Gonzalez-Escalona, N., Gavilan, R. G., Brown, E. W., and Martinez-
Urtaza, J. (2015). Transoceanic spreading of pathogenic strains of Vibrio
parahaemolyticus with distinctive genetic signatures in the recA gene. PLoS
ONE 10:e0117485. doi: 10.1371/journal.pone.0117485
Gonzalez-Escalona, N., Martinez-Urtaza, J., Romero, J., Espejo, R. T., Jaykus,
L. A., and DePaola, A. (2008). Determination of molecular phylogenetics of
Vibrio parahaemolyticus strains bymultilocus sequence typing. J. Bacteriol. 190,
2831–2840. doi: 10.1128/JB.01808-07
Harth-Chu, E., Espejo, R. T., Christen, R., Guzman, C. A., and Hofle,
M. G. (2009). Multiple-locus variable-number tandem-repeat analysis
for clonal identification of Vibrio parahaemolyticus isolates by using
capillary electrophoresis. Appl. Environ. Microbiol. 75, 4079–4088. doi:
10.1128/AEM.02729-08
Hayat, U., Reddy, G. P., Bush, C. A., Johnson, J. A., Wright, A. C., Morris, J.
G., et al. (1993). Capsular types of Vibrio vulnificus: an analysis of strains
from clinical and environmental sources. J. Infect. Dis. 168, 758–762. doi:
10.1093/infdis/168.3.758
Hyytia-Trees, E., Smole, S. C., Fields, P. A., Swaminathan, B., and Ribot,
E. M. (2006). Second generation subtyping: a proposed PulseNet protocol
for multiple-locus variable-number tandem repeat analysis of Shiga toxin-
producing Escherichia coli O157 (STEC O157). Foodborne. Pathog. Dis. 3,
118–131. doi: 10.1089/fpd.2006.3.118
Iwamoto, M., Ayers, T., Mahon, B. E., and Swerdlow, D. L. (2010). Epidemiology
of seafood-associated infections in the United States. Clin. Microbiol. Rev. 23,
399–411. doi: 10.1128/CMR.00059-09
Jones, J. L., Ludeke, C. H., Bowers, J. C., Garrett, N., Fischer, M., Parsons, M. B.,
et al. (2012). Biochemical, serological, and virulence characterization of clinical
and oyster Vibrio parahaemolyticus isolates. J. Clin. Microbiol. 50, 2343–2352.
doi: 10.1128/JCM.00196-12
Kimura, B., Sekine, Y., Takahashi, H., Tanaka, Y., Obata, H., Kai, A., et al. (2008).
Multiple-locus variable-number of tandem-repeats analysis distinguishes
Vibrio parahaemolyticus pandemic O3:K6 strains. J. Microbiol. Methods 72,
313–320. doi: 10.1016/j.mimet.2007.12.014
Lindstedt, B. A. (2005). Multiple-locus variable number tandem repeats analysis
for genetic fingerprinting of pathogenic bacteria. Electrophoresis 26, 2567–2582.
doi: 10.1002/elps.200500096
Lindstedt, B. A., Torpdahl, M., Vergnaud, G., Le, H. S., Weill, F. X., Tietze, E., et al.
(2013). Use of multilocus variable-number tandem repeat analysis (MLVA) in
eight European countries, 2012. Euro. Surveill. 18:20385.
Ludeke, C. H., Fischer, M., LaFon, P., Cooper, K., and Jones, J. L. (2014).
Suitability of the molecular subtyping methods intergenic spacer region, direct
genome restriction analysis, and pulsed-field gel electrophoresis for clinical and
Frontiers in Microbiology | www.frontiersin.org 9 June 2015 | Volume 6 | Article 564
Lüdeke et al. MLST and MLVA for V. parahaemolyticus
environmental Vibrio parahaemolyticus isolates. Foodborne. Pathog. Dis. 11,
520–528. doi: 10.1089/fpd.2013.1728
Maiden, M. C., Bygraves, J. A., Feil, E., Morelli, G., Russell, J. E., Urwin, R., et al.
(1998). Multilocus sequence typing: a portable approach to the identification of
clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci.
U.S.A. 95, 3140–3145. doi: 10.1073/pnas.95.6.3140
Maiden,M. C., Jansen van Rensburg,M. J., Bray, J. E., Earle, S. G., Ford, S. A., Jolley,
K. A., et al. (2013). MLST revisited: the gene-by-gene approach to bacterial
genomics. Nat. Rev. Microbiol. 11, 728–736. doi: 10.1038/nrmicro3093
Martinez-Urtaza, J., Baker-Austin, C., Jones, J. L., Newton, A. E., Gonzalez-
Aviles, G. D., and DePaola, A. (2013). Spread of Pacific Northwest
Vibrio parahaemolyticus strain. N. Engl. J. Med. 369, 1573–1574. doi:
10.1056/NEJMc1305535
Nishibuchi, M., and DePaola, A. (2005). “Vibrio spp.,” in Foodborne Pathogens:
Microbiology and Molecular Biology, eds P. M. Fratamico, A. K. Bhunia, and
J. L. Smith (Norfolk: Caister Academic Press), 251–271.
Paranjpye, R., Hamel, O. S., Stojanovski, A., and Liermann, M. (2012). Genetic
diversity of clinical and environmental Vibrio parahaemolyticus strains
from the Pacific Northwest. Appl. Environ. Microbiol. 78, 8631–8638. doi:
10.1128/AEM.01531-12
Perez-Losada, M., Cabezas, P., Castro-Nallar, E., and Crandall, K. A. (2013).
Pathogen typing in the genomics era: MLST and the future of molecular
epidemiology. Infect. Genet. Evol. 16, 38–53. doi: 10.1016/j.meegid.2013.
01.009
Tamura, K., Stecher, G., Peterson, D., Filipski, A., and Kumar, S. (2013). MEGA6:
Molecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 30,
2725–2729. doi: 10.1093/molbev/mst197
Turner, J. W., Paranjpye, R. N., Landis, E. D., Biryukov, S. V., Gonzalez-
Escalona, N., Nilsson, W. B., et al. (2013). Population structure of clinical and
environmental Vibrio parahaemolyticus from the Pacific Northwest coast of the
United States. PLoS ONE 8:e55726. doi: 10.1371/journal.pone.0055726
van Belkum, A. (2007). Tracing isolates of bacterial species by multilocus variable
number of tandem repeat analysis (MLVA). FEMS Immunol. Med. Microbiol.
49, 22–27. doi: 10.1111/j.1574-695X.2006.00173.x
Xu, F., Ilyas, S., Hall, J. A., Jones, S. H., Cooper, V. S., and Whistler, C. A. (2015).
Genetic characterization of clinical and environmentalVibrio parahaemolyticus
from the Northeast USA reveals emerging resident and non-indigenous
pathogen lineages. Front. Microbiol. 6:272. doi: 10.3389/fmicb.2015.00272
Yan, Y., Cui, Y., Han, H., Xiao, X., Wong, H. C., Tan, Y., et al. (2011). Extended
MLST-based population genetics and phylogeny of Vibrio parahaemolyticus
with high levels of recombination. Int. J. Food Microbiol. 145, 106–112. doi:
10.1016/j.ijfoodmicro.2010.11.038
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Lüdeke, Gonzalez-Escalona, Fischer and Jones. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Microbiology | www.frontiersin.org 10 June 2015 | Volume 6 | Article 564
